Clinical studies have shown poor prognoses for patients with most subtypes of peripheral T-cell lymphoma (PTCL), especially for those who have received conventional chemotherapy, as well as high relapse and low overall survival rates, but doctors said a new antifolate could be an effective alternative to traditional treatments.
Chang Ming-chih (張明志), consultant hematologist and oncologist at Mackay Memorial Hospital, said an average of about 330 PTCL cases were reported in Taiwan each year in the past few years and the numbers appear to be growing, adding that there are many different types of PTCL and most of them are aggressive.
Chang said that a study conducted overseas in 2013 showed that the three-year survival rate of PTCL patients after their first relapse was only 18 percent, adding that survival rates can be increased significantly for those who receive hematopoietic stem cell transplantations (HSCT).
Photo: Ruby Chang
However, patients are sometimes too weak to undergo HSCT due to age or the side effects of conventional chemotherapy, or they are unwilling to accept treatment due the to high relapse rate, he said, adding that the average lifespan of PTCL patients after their first relapse or progression is about five-and-a-half months without HSCT.
Chang said that a new antifolate — Pralatrexate — has been proven to extend the duration of a response from therapy, which means it might give patients the chance to undergo HSCT and increase their survival rate.
Speaking in Taipei last weekend, Owen A. O’Connor, a professor of medicine and experimental therapeutics and the director of the Center for Lymphoid Malignancies at Columbia University Medical Center, said that the antifolate works by mimicking folic acids to selectively enter cells expressing RFC-1, a protein that is expressed in certain cancer cells but seldom in normal cells.
Once inside cancer cells, the Pralatrexate acts on the folate pathway, interfering with DNA synthesis and suppressing the growth of the cancer cell, he said.
A clinical study conducted on more than 100 adult patients with relapsed or refractory PTCL showed that the average response rate to the new drug was 29 percent and the average duration of response was 12 months, O’Connor said.
In most parts of the world, the typical frontline treatment for PTCL is a combination of chemotherapy commonly known as CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone), but only up to 20 percent of the patients that undergo CHOP are expected to be cured, he said.
The most common solution for treating patients who did not respond to CHOP is to give them more chemotherapy, but for patients with T-cell lymphoma, cancer cells become resistant to many types of chemotherapy, O’Conner said, adding: “So we need new drugs that work in a different mechanism from traditional chemotherapy.”
“It is important for doctors and patients alike to recognize that chemotherapy might not always be the answer, and to think about how to use new drugs as a bridge to curative therapy like transplantation or a strategy to manage the disease for long periods of time,” he said, adding that Pralatrexate has exhibited marked and durable activity in heavily treated patients across all subtypes of PTCL.
Chang said that lymphoma might develop in many parts of the body and there are many types and subtypes of the disease, so sometimes patients and physicians might have difficulty diagnosing it.
He advised people to see a doctor if they have the following symptoms: swelling in the whole body or in the neck or the armpits; painless lymph node enlargement; high fever for more than two weeks; night sweats; loss of 3 to 5 percent or more of body weight within six months; fatigue or nasal congestion (similar to sinusitis, but with bleeding).
A group of Taiwanese-American and Tibetan-American students at Harvard University on Saturday disrupted Chinese Ambassador to the US Xie Feng’s (謝鋒) speech at the school, accusing him of being responsible for numerous human rights violations. Four students — two Taiwanese Americans and two from Tibet — held up banners inside a conference hall where Xie was delivering a speech at the opening ceremony of the Harvard Kennedy School China Conference 2024. In a video clip provided by the Coalition of Students Resisting the CCP (Chinese Communist Party), Taiwanese-American Cosette Wu (吳亭樺) and Tibetan-American Tsering Yangchen are seen holding banners that together read:
UNAWARE: Many people sit for long hours every day and eat unhealthy foods, putting them at greater risk of developing one of the ‘three highs,’ an expert said More than 30 percent of adults aged 40 or older who underwent a government-funded health exam were unaware they had at least one of the “three highs” — high blood pressure, high blood lipids or high blood sugar, the Health Promotion Administration (HPA) said yesterday. Among adults aged 40 or older who said they did not have any of the “three highs” before taking the health exam, more than 30 percent were found to have at least one of them, Adult Preventive Health Examination Service data from 2022 showed. People with long-term medical conditions such as hypertension or diabetes usually do not
POLICE INVESTIGATING: A man said he quit his job as a nurse at Taipei Tzu Chi Hospital as he had been ‘disgusted’ by the behavior of his colleagues A man yesterday morning wrote online that he had witnessed nurses taking photographs and touching anesthetized patients inappropriately in Taipei Tzu Chi Hospital’s operating theaters. The man surnamed Huang (黃) wrote on the Professional Technology Temple bulletin board that during his six-month stint as a nurse at the hospital, he had seen nurses taking pictures of patients, including of their private parts, after they were anesthetized. Some nurses had also touched patients inappropriately and children were among those photographed, he said. Huang said this “disgusted” him “so much” that “he felt the need to reveal these unethical acts in the operating theater
Heat advisories were in effect for nine administrative regions yesterday afternoon as warm southwesterly winds pushed temperatures above 38°C in parts of southern Taiwan, the Central Weather Administration (CWA) said. As of 3:30pm yesterday, Tainan’s Yujing District (玉井) had recorded the day’s highest temperature of 39.7°C, though the measurement will not be included in Taiwan’s official heat records since Yujing is an automatic rather than manually operated weather station, the CWA said. Highs recorded in other areas were 38.7°C in Kaohsiung’s Neimen District (內門), 38.2°C in Chiayi City and 38.1°C in Pingtung’s Sandimen Township (三地門), CWA data showed. The spell of scorching